The antinociceptive effect of zolpidem and zopiclone in mice.

作者: C PICK , Y CHERNES , T RIGAI , K RICE , S SCHREIBER

DOI: 10.1016/J.PBB.2005.02.013

关键词:

摘要: Zolpidem and zopiclone are two of a newer hypno-sedative class drugs, the "Z compounds". Their use for treatment short-term insomnia has been expanding constantly during last decades. The compounds" considered to cause less significant rebound or tolerance than conventional hypnotic benzodiazepines. possible antinociceptive effect interaction with opioid system not studied yet. Our results demonstrate difference between properties zolpidem when injected s.c. in hotplate analgesic assay mice. Zopiclone induced weak, dose-dependent effect, antagonized only by alpha2-adrenergic receptor antagonist yohimbine. biphasic primarily non-selective naloxone weak both evident at very high doses (far beyond those used clinically induce sleep), implies no clinical management pain. However, should be further investigated (in behavioral models, which do overlap acute-pain antinociception model we used), side effects special populations (i.e. elderly) drug-drug interactions, order minimize hazards maximize beneficial its sleep.

参考文章(53)
Steinberg R, Berger M, Clarenbach P, Weess Hg, Recommendations for the diagnosis and therapy of insomnia. German Society of Sleep Research and Sleep Medicine DGSM Nervenarzt. ,vol. 66, pp. 723- 729 ,(1995)
H. Chevalier, F. Los, D. Boichut, M. Bianchi, D. J. Nutt, G. Hajak, J. Hetta, G. Hoffmann, C. Crowe, Evaluation of severe insomnia in the general population: results of a European multinational survey. Journal of Psychopharmacology. ,vol. 13, ,(1999) , 10.1177/026988119901304S04
Busto Ue, Knight K, Herrmann N, Sproule Ba, Use of prescription and nonprescription hypnotics in a Canadian elderly population. The Canadian journal of clinical pharmacology. ,vol. 8, pp. 213- ,(2001)
H.-U. Wittchen, D. Riemann, M. Höfler, P. Krause, H. Pfister, D. Pittrow, B. Spiegel, S. Winter, G. Hajak, A. Steiger, NISAS-2000 - die "Nationwide insomnia screening and awareness study". Insomnien und Schlafstörungen in der allgemeinärztlichen Versorgung. Nervenheilkunde. ,vol. 20, pp. 4- 16 ,(2001)
M. Soyka, R. Bottlender, H.-J. Möller, Epidemiological evidence for a low abuse potential of zolpidem. Pharmacopsychiatry. ,vol. 33, pp. 138- 141 ,(2000) , 10.1055/S-2000-11224
B.W. Urban, P. Friederich, Anesthetic mechanisms in-vitro and in general anesthesia. Toxicology Letters. ,vol. 100, pp. 9- 16 ,(1998) , 10.1016/S0378-4274(98)00159-3
John Markowitz, Timothy Brewerton, Zolpidem-induced psychosis. Annals of Clinical Psychiatry. ,vol. 8, pp. 89- 91 ,(1996) , 10.3109/10401239609148806